Compare Fox Corp Class A (FOXA) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Fox Corp Class A trades at $62.83 (market cap $25.36B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.43 (market cap $6.04B). The key difference: Fox Corp Class A is far larger — about 4.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Fox Corp Class A pays a 0.91% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class A for 34 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FOXA | IOVA | |
|---|---|---|
Market Cap | $25.36B | $6.04B |
Volume | 2,566,954 | 14,805,993 |
Sector | Media | Health |
52-Week High | $76.11 | $14.82 |
52-Week Low | $48.79 | $1.81 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $28.72B | $5.97B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOXA trades at $63.42, up 1.15% with a bullish technical signal and strong fundamental performance. The stock shows robust earnings momentum with three consecutive quarterly beats and solid profitability metrics including 14.29% ROE and 9.84% net margin. Recent news highlights the pending Roku acquisition and regulatory scrutiny, while institutional activity shows CEO Lachlan Murdoch's significant $10.3 million share purchase in September 2026.
The outlook remains positive with a $72 consensus price target representing 13.5% upside potential. Key opportunities include continued earnings growth and strategic acquisitions, while risks center on regulatory approval for the Roku deal and potential market volatility. With no analyst sell ratings and strong institutional support, FOXA presents a compelling investment case in the media sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
